Manufacturing / Pharmaceutical Preparations
UNITED THERAPEUTICS Corp
UTHR
$536.37
+$3.88 (+0.72%)
24 B
Market Cap (Large Cap)
15%
IV Rank
36.4%
Implied Volatility
Jul 28
Next Earnings
Insider Trades
1 buys
1886 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | ROTHBLATT MARTINE A | Exercise | 9,500 | $1,387,285 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 75 | $40,414 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 205 | $110,787 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 200 | $108,322 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 440 | $239,145 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 809 | $441,315 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 470 | $256,726 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 482 | $263,956 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 1,459 | $800,299 | |
| Jun 15, 2026 | ROTHBLATT MARTINE A | Sell | 732 | $402,276 |
Politician Trades in UTHR
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| Oct 31, 2025 | Lisa C. McClain | R | Sale | $1K-$15K |
| Oct 30, 2025 | Lisa C. McClain | R | Purchase | $1K-$15K |
| Oct 30, 2025 | Lisa C. McClain | R | Sale | $1K-$15K |
| Oct 27, 2025 | Michael T. McCaul | R | Sale | $15K-$50K |
| Aug 22, 2025 | Michael T. McCaul | R | Sale | $50K-$100K |
| Aug 07, 2025 | Michael T. McCaul | R | Purchase | $50K-$100K |
| Jun 27, 2025 | Michael T. McCaul | R | Sale | $100K-$250K |
| Jun 11, 2025 | Lisa C. McClain | R | Purchase | $1K-$15K |
| Nov 20, 2024 | Michael T. McCaul | R | Sale | $15K-$50K |
| Nov 20, 2024 | Michael T. McCaul | R | Sale | $100K-$250K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $7.01 | $5.82 | -16.9% | Miss |
| Dec 31, 2025 | Q4 2025 | $7.33 | $7.70 | +5.1% | Beat |
| Sep 30, 2025 | Q3 2025 | $7.33 | $7.16 | -2.3% | Miss |
| Jun 30, 2025 | Q2 2025 | $7.08 | $6.41 | -9.5% | Miss |
Track UTHR with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for UTHR and your entire portfolio.